Categories AlphaGraphs, Earnings

Earnings preview: What to look for when Delta Air Lines reports Q2 2019 earnings results

Delta Air Lines Inc. (NYSE: DAL) is scheduled to report second quarter 2019 earnings results on Thursday, July 11, before market open. Wall Street anticipates earnings of $2.24 per share on revenue of $12.4 billion, reflecting year-over-year increases of 26% and 5% respectively.

Looking at the trailing four quarters, the company has consistently topped earnings estimates, which provides optimism for the to-be reported quarter. The results are expected to benefit from a double-digit growth in domestic corporate revenue as well as strong core performance.

Delta has an advantage in terms of not being affected by the trade war or the Boeing crisis as the company does not have any Boeing Max 737 jets in its fleet. For the month of June, Delta reported a 6.2% increase in revenue passenger miles compared to the same period last year. Capacity was up by 4% with a load factor of 90.4%.

In the first quarter of 2019, Delta beat revenue and earnings estimates with revenues growing 5% year-over-year to $10.5 billion and adjusted EPS climbing 28% to $0.96.

Delta Air Lines Q1 profit rises on higher revenues, beat estimates

Last week, Delta raised its guidance for the June quarter and the company now expects adjusted EPS to be $2.25-2.35 along with adjusted pretax margin of 15-16%. Total adjusted revenue is expected to grow 8-8.5% while TRASM is expected to grow around 3.5%.

Delta’s shares have climbed 18% thus far this year and over 2% in the past three months. The majority of analysts are bullish on Delta and have rated the stock as Buy with an average price target of $69.56.

Delta’s competitor American Airlines (NYSE: AAL) will report earnings on July 26.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top